Edwards Lifesciences Corp (NYSE:EW)

130.72
Delayed Data
As of May 29
 +0.07 / +0.05%
Today’s Change
78.12
Today|||52-Week Range
150.41
+2.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line547.0M94.6M109.2M123.4M
 
 
 
 
 
Depreciation16.1M18.0M18.3M16.0M
 
 
 
 
 
Total Other Cash Flow3.0M-2.0M14.0M2.5M
 
 
 
 
 
Funds From Operations567.4M110.8M68.2M146.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-210.6M98.6M-25.0M72.7M
 
 
 
 
 
Net Cash Flow - Operating Activities778.0M12.2M93.2M73.3M
 
 
 
 
 
 
InvestingIncrease In Investments-754.5M-454.4M-516.2M-509.0M
 
 
 
 
 
Decrease In Investments299.4M317.4M701.4M349.2M
 
 
 
 
 
Capital Expenditures-16.0M-18.1M-34.5M-20.8M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-15.0M0.00
 
 
Other Investing - Uses0.000.00-10.8M0.00
 
 
Other Investing - Sources700.0K300.0K-1.6M300.0K
 
 
 
 
 
Net Cash Flow Investing-470.4M-154.8M112.0M-180.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings5.8M6.2M6.0M7.4M
 
 
 
 
 
Long Term Debt Reduction-134.6M-6.1M-20.0M-8.2M
 
 
 
 
 
Net Proceeds Stock Sale18.7M38.4M42.0M23.5M
 
 
 
 
 
Common Preferred Redeemed-600.0K-100.0K-200.0K-101.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing7.3M12.9M15.2M9.8M
 
 
 
 
 
Other Uses - Financing400.0K2.6M-2.9M3.4M
 
 
 
 
 
Net Cash Flow - Financing-103.8M48.7M45.9M-71.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-900.0K-600.0K-1.4M-17.9M
 
 
 
 
 
 
Net Change In Cash203.8M-93.9M251.1M-178.9M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account